Rare Diseases -- Not Just for Geneticists Anymore
Drs Summar and Saul discuss gaps in education for all clinicians, as pediatric and other rare disease patients live longer, transition to adulthood, and rewrite natural histories of their diseases. (Source: Medscape Pediatrics Podcast)
Source: Medscape Pediatrics Podcast - February 24, 2016 Category: Pediatrics Authors: Medscape Source Type: podcasts

February 23 2016 Issue
1) Neurology® Genetics: Late diagnosis of cerebral folate deficiency: Fewer seizures with folinic acid in adult siblings 2) e-Pearl topic: Stroke-like migraine attacks after radiation therapy (SMART) Syndrome3) Topic of the month: Neurology Today story about unraveling the genetics of Alzheimer disease and attending the ‘Oscars of Science' This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Nathan Fountain interviews Dr. Dave Dyment about his Neurology: Genetics paper o...
Source: Neurology Podcast - February 23, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts

How Do Genetic Testing and Targeted Therapy Fit in CLL?
Dr. Michael Keating of MD Anderson and Dr. Nicole Lamanna of Columbia University give a thorough description of FISH and CLL profiling, emphasizing the need to get the right test done at the right tim... Author: P2Professional Added: 02/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2016 Category: Cancer & Oncology Source Type: podcasts

Targeting genetic abnormalities for papillary and follicular carcinoma #hncs16
Dr. Keith C. Bible, MD or the Mayo Clinic discusses targeting genetic abnormalities and signaling pathways for papillary and follicular carcinoma at ASTRO Head and Neck Symposium Author: ASTROHN2016 Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts

Is It Possible for Genetic Mutations in MPNs to Affect Treatment Choices?
MPN expert Dr. Rami Komrokji of Moffitt Cancer Center discusses various genetic marker subsets of myeloproliferative neoplasms (MPNs) and how these alterations affect what type of treatment a patient ... Author: P2Professional Added: 02/17/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 18, 2016 Category: Cancer & Oncology Source Type: podcasts

How Do Genetic Testing and Targeted Therapy Fit in CLL?
Dr. Michael Keating of MD Anderson and Dr. Nicole Lamanna of Columbia University give a thorough description of FISH and CLL profiling, emphasizing the need to get the right test done at the right tim... Author: patientpower Added: 02/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 16, 2016 Category: Cancer & Oncology Source Type: podcasts

Is It Possible for Genetic Mutations in MPNs to Affect Treatment Choices?
MPN expert Dr. Rami Komrokji of Moffitt Cancer Center discusses various genetic marker subsets of myeloproliferative neoplasms (MPNs) and how these alterations affect what type of treatment a patient ... Author: patientpower Added: 02/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 13, 2016 Category: Cancer & Oncology Source Type: podcasts

Should Genetic Tests Be Repeated?
Patient Power founder Andrew Schorr visits with Dr. Michael Keating of MD Anderson Cancer Center to ask audience questions about repeat genetic testing. Dr. Keating discusses which tests are essential... Author: P2Professional Added: 02/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 10, 2016 Category: Cancer & Oncology Source Type: podcasts

Should Genetic Tests Be Repeated?
Patient Power founder Andrew Schorr visits with Dr. Michael Keating of MD Anderson Cancer Center to ask audience questions about repeat genetic testing. Dr. Keating discusses which tests are essential... Author: patientpower Added: 02/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 10, 2016 Category: Cancer & Oncology Source Type: podcasts

February 9 2016 Issue
1) Mid-life milk consumption and substantia nigra neuron density at death2) What's Trending: Interview with Dr. Ray Dorsey about new Neurology site, which will be called Innovations in Care Delivery3) Topic of the month: Neurology Today story about should there be a moratorium on human germline editingThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Robert Abbott about his paper on mid-life milk consumption and substantia nigra neuro density at death....
Source: Neurology Podcast - February 9, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts

February 9 2016 Issue
1) Mid-life milk consumption and substantia nigra neuron density at death2) What's Trending: Interview with Dr. Ray Dorsey about new Neurology site, which will be called Innovations in Care Delivery3) Topic of the month: Neurology Today story about should there be a moratorium on human germline editingThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Robert Abbott about his paper on mid-life milk consumption and substantia nigra neuro density at death....
Source: Neurology Podcast - February 9, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts

Pharmacogenetic Testing for 5-FU Saves Lives and Money
Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it. (Source: Medscape Oncology)
Source: Medscape Oncology - February 5, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Pharmacogenetic Testing for 5-FU Saves Lives and Money
Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - February 5, 2016 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts

Podcast: Taking race out of genetics, a cellular cleanse for longer life, and smart sweatbands
Online news editor David Grimm shares stories on killing cells to lengthen life, getting mom’s microbes after a C-section, and an advanced fitness tracker that sits on the wrist and sips sweat. Michael Yudell joins host Sarah Crespi to discuss an initiative to replace race in genetics with more biologically meaningful terms, and Lena Wilfert talks about drivers of the global spread of the bee-killing deformed wing virus.   [Image: Vipin Baliga/(CC BY 2.0)] (Source: Science Magazine Podcast)
Source: Science Magazine Podcast - February 4, 2016 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Episode 33: Genetics in Space
Improving human health on and off the Earth's surface (Source: Harvard Medical Labcast)
Source: Harvard Medical Labcast - February 2, 2016 Category: Biomedical Science Authors: Harvard Medical School Office of Communications and External Relations Source Type: podcasts

Redefining genetic counselling for ovarian cancer care
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Prof Jonathan A. Ledermann, from UCL Cancer Institute and UCL Hospitals,... Author: PatientPowerEU Added: 01/30/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2016 Category: Cancer & Oncology Source Type: podcasts

A new definition of genetic counselling for ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Jonathan A. Ledermann, BSc, MD, FRCP, from UCL Cancer Institute and UCL ... Author: EMJ Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts

Predisposition to MPN and MDS: Pertinent Family History, Genetic Testing and Counseling
As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals who treat these diseases are provided exper... Author: imedex Added: 01/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Current Understanding of a Genetic/Epigenetic Basis of MDS
As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals who treat these diseases are provided exper... Author: imedex Added: 01/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Current Understanding of a Genetic/Epigenetic Basis of Classic MPNs
As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals who treat these diseases are provided exper... Author: imedex Added: 01/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Phenotypic Manifestation of Genetic Risk for Schizophrenia (JAMA Psychiatry)
Interview with Stanley Zammit, MRCPsych, PhD, author of Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 27, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA Psychiatry : Phenotypic Manifestation of Genetic Risk for Schizophrenia
Interview with Stanley Zammit, MRCPsych, PhD, author of Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 27, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

Does Genetic Test 'Decipher' PCa Risk After Prostatectomy?
The new Decipher genetic test may more accurately predict risk for metastasis following radical prostatectomy for prostate cancer, but will it improve outcomes? (Source: Medscape Oncology)
Source: Medscape Oncology - January 26, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts

Does Genetic Test 'Decipher' PCa Risk After Prostatectomy?
The new Decipher genetic test may more accurately predict risk for metastasis following radical prostatectomy for prostate cancer, but will it improve outcomes? (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - January 26, 2016 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts

Pazienti con leucemia e difetto genetico del gene p53
Il dottor Paolo Ghia, Professore Associato di Medicina Interna Vita-Salute San Raffaele (Milano) al Congresso Annuale dell’ASH (American Society of Hematology) del 2015 interviene riguardo alla terap... Author: PatientPowerEU Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2016 Category: Cancer & Oncology Source Type: podcasts

Pazienti con leucemia e difetto genetico del gene p53
Il dottor Paolo Ghia, Professore Associato di Medicina Interna Vita-Salute San Raffaele (Milano) al Congresso Annuale dell’ASH (American Society of Hematology) del 2015 interviene riguardo alla terap... Author: PatientPowerEU Added: 01/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2016 Category: Cancer & Oncology Source Type: podcasts

ASCO GU 2016 Genetic Testing in Prostate Cancer
Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses Genetic Testing in Prostate Cancer at ASCO GU 2016 Author: 2016_Genitourinary Added: 01/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

ASH Clinical News: Predicting Prognosis in Myelodysplastic Syndromes
Rafael Bejar, MD, PhD talks to ASH Clinical News at the 57th ASH Annual Meeting about how genetic mutations can be incorporated into prognostic scoring systems for myelodysplastic syndromes. Genetic m... Author: ash Added: 01/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2016 Category: Cancer & Oncology Source Type: podcasts

Dr. Nicole Lamanna: CLL Updates from ASH 2015
Are clinical trials still a good idea for patients? Is there still a place for chemo? Who should get genetic testing and when should it be done? Dr. Nicole Lamanna, Associate Clinical Professor of Med... Author: patientpower Added: 12/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2015 Category: Cancer & Oncology Source Type: podcasts

Targeted cancer therapy 101 (sponsored by seattle genetics)
Sponsored by Seattle Genetics, in this episode of The Stupid Cancer Show, we're tackling the issue of next generation targeted immunotherapy drugs. Joining us to share his expertise is Dr. John Godwin, a leading expert in immunotherapy, targeted therapy, and other “new” treatment options for patients with cancer. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - December 15, 2015 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

December 15 2015 Issue
1) Neurology® Neuroimmunology & Neuroinflammation Journal: Basal ganglia T1-hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures and 2) Topic of the month: Neurology Today: Recent Publications. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Waugh interviews Dr. Eoin Flanagan about his Neurology: Neuroimmunology & Neuroinflammation paper on basal ganglia T1-hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Dr. Adam Numis is r...
Source: Neurology Podcast - December 15, 2015 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts

Immunotherapy 101 (sponsored by seattle genetics)
Sponsored by Seattle Genetics, in this episode of The Stupid Cancer Show, we're tackling the issue of next generation targeted immunotherapy drugs. Joining us to share his expertise is Dr. John Godwin, a leading expert in immunotherapy, targeted therapy, and other “new” treatment options for patients with cancer. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - December 12, 2015 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

Can Patients Benefit from Broad vs. Focal Genetic Testing?
Drs. Ben Solomon, Leora Horn, & Jack West evaluate the merits of broad genetic testing with a "next generation sequencing" platform compared to selective, limited testing for the most pr... Author: cancergrace Added: 12/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2015 Category: Cancer & Oncology Source Type: podcasts

Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Press brief by James N. Kochenderfer, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Kochenderfer provides an overview of a trial of allogeneic T-cells that were genetically ... Author: EMJ Added: 12/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 10, 2015 Category: Cancer & Oncology Source Type: podcasts

Molecular drivers of metastatic disease in breast cancer | Dr Giuseppe Curigliano at ECC 2015
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer... Author: EMJ Added: 11/23/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

TWiV 364: It's not SARS 2.0
Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler Guests: Ralph Baric and Vineet Menachery Vincent, Rich, and Kathy speak with Ralph and Vineet about their research on the potential of SARS-like bat coronaviruses  to infect human cells and cause disease in mice.   Links for this episode Zoonotic potential of SARS-like bat viruses (Nature) SARS-CoV susceptibility loci via collaborative cross (PLoS Genetics) Ebright and Wain-Hobson quotes (Nature) Misleading press release (UNC) Super powerful SARS 2.0 (not!) (Motherboard) SARS...
Source: This Week in Virology - MP3 Edition - November 22, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome
In this informative web chat, genetic counselor, Megan Myers, discusses what Lynch syndrome is, how you can learn if you have Lynch syndrome, and the things you can do to help prevent or reduce your c... Author: cancerconnectasktheexpert Added: 11/19/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 19, 2015 Category: Cancer & Oncology Source Type: podcasts

Hereditary Breast and Ovarian Cancer: What you need to know about risk and prevention
In this informative web chat, Megan Myers discusses hereditary breast and ovarian cancer (HBOC) syndrome risk, diagnosis, and cancer prevention strategies. Megan Myers is a genetic counselor in the Ga... Author: cancerconnectasktheexpert Added: 11/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 18, 2015 Category: Cancer & Oncology Source Type: podcasts

The Latest in Genetics and Women’s Cancers
CancerConnect recently partnered with Dana-Farber Cancer Institute to provide you with the opportunity to engage with cancer genetics and prevention expert Judy E. Garber, MD, MPH. In this informative... Author: cancerconnectasktheexpert Added: 11/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 18, 2015 Category: Cancer & Oncology Source Type: podcasts

Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma | Prof Grant McArthur
At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria, Australia, discusses the impact of baseline genetic heterogeneitie... Author: EMJ Added: 11/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2015 Category: Cancer & Oncology Source Type: podcasts

What Is the Meaning Between PV and Genetics?
With the advent of unlocking genetic code, the cancer community has now been introduced to the concept of immunotherapy. What does this mean specifically for MPN patients? For MPN expert Dr. Srdan Ver... Author: P2Professional Added: 11/12/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2015 Category: Cancer & Oncology Source Type: podcasts

High-Risk CLL: Advances in Treatment
CLL patients with certain genetic markers are considered to be “high risk” and their options for treatment have historically been limited. CLL expert Dr. Jeff Sharman joins Patient Power to discuss em... Author: P2Professional Added: 11/12/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2015 Category: Cancer & Oncology Source Type: podcasts

What Is the Meaning Between PV and Genetics?
With the advent of unlocking genetic code, the cancer community has now been introduced to the concept of immunotherapy. What does this mean specifically for MPN patients? For MPN expert Dr. Srdan Ver... Author: patientpower Added: 11/12/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 12, 2015 Category: Cancer & Oncology Source Type: podcasts

High-Risk CLL: Advances in Treatment
CLL patients with certain genetic markers are considered to be “high risk” and their options for treatment have historically been limited. CLL expert Dr. Jeff Sharman joins Patient Power to discuss em... Author: patientpower Added: 11/12/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 12, 2015 Category: Cancer & Oncology Source Type: podcasts

Update on Molecular and Genetic Characterization of RCC
A Ari Hakimi MD Memorial Sloan Kettering Cancer Center brings an "Update on Molecular and Genetic Characterization of RCC" at the 14th International Kidney Cancer Symposium (Kidney Cancer As... Author: kidneycancer Added: 11/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2015 Category: Cancer & Oncology Source Type: podcasts

Food Labeling: Yes or No for GMO?
Do you think genetically modified food should be labeled as such? Dr Art Caplan, ethicist, shares his opinion here. (Source: Medscape Business of Medicine Podcast)
Source: Medscape Business of Medicine Podcast - October 20, 2015 Category: Health Management Authors: Medscape Source Type: podcasts